P-glycoprotein: so many ways to turn it on

Richard Callaghan1, Emily Crowley, Simon Potter

  • 1Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK. richard.callaghan@ndcls.ox.ac.uk

Insights

P-glycoprotein (P-gp or ABCB1) expression drives chemotherapy resistance via cellular stress. However, ABCB1 in normal tissues functions differently, impacting drug pharmacokinetics without stress response involvement.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cancer Biology

Background:

  • P-glycoprotein (P-gp or ABCB1) is an ABC transporter linked to chemotherapy resistance in cancer.
  • ABCB1 expression is regulated by cellular stress pathways, triggered by chemotherapy or hypoxia.
  • ABCB1 is also present in noncancerous tissues, particularly at barrier and secretory sites.

Purpose of the Study:

  • To review the regulation of ABCB1 expression in both cancerous and noncancerous tissues.
  • To elucidate the distinct mechanisms of ABCB1 expression in normal tissues.
  • To understand the impact of ABCB1 localization on drug pharmacokinetics.

Main Methods:

  • Literature review of studies on ABCB1 expression and regulation.
  • Analysis of ABCB1 localization in normal physiological barriers.
  • Comparison of ABCB1 regulation in cancer versus noncancerous tissues.

Main Results:

  • ABCB1 expression in cancer is often linked to cellular stress responses.
  • ABCB1 is found in barrier tissues (e.g., blood-brain barrier, gut epithelium) and secretory organs.
  • ABCB1 expression in noncancerous tissues does not appear to involve the classical stress response pathway.

Conclusions:

  • ABCB1 plays a critical role in drug pharmacokinetics, affecting absorption and elimination due to its presence in normal tissues.
  • Understanding the distinct regulatory mechanisms of ABCB1 in normal tissues is crucial for drug development and treatment strategies.
  • The differential regulation of ABCB1 highlights its complex role beyond chemotherapy resistance.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...